Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05929014 Completed - Healthy Clinical Trials

The Effect of Different Intensities of Bilateral- and Cathodal-tDCS in Healthy Individuals

Start date: June 24, 2023
Phase: N/A
Study type: Interventional

This study will be divided into 2 sub-study 1) To investigate the effects of 1 mA, 1.5 mA, and 2 mA of bilateral- tDCS on cortical activity and motor/cognitive performances in healthy individuals 2) To investigate the effects of 1 mA, 1.5 mA, and 2 mA of cathodal-tDCS on cortical activity and motor/cognitive performances in healthy individuals.

NCT ID: NCT05928988 Completed - Healthy Clinical Trials

A Study to Evaluate the Effect of Itraconazole on Pharmacokinetics (PK) of SHR8554 in Healthy Adult Subjects

Start date: January 4, 2022
Phase: Phase 1
Study type: Interventional

This drug-drug interaction (DDI) study has been designed to characterize the pharmacokinetic profile of SHR8554 when co administered with a strong cytochrome P450 3A4 (CYP3A4) inhibitor itraconazole

NCT ID: NCT05927675 Completed - Healthy Clinical Trials

Changes in Microbiome and Metabolites Regarding Physical Activity in Middle-aged Korean Women

Start date: May 10, 2019
Phase: N/A
Study type: Interventional

This study aimed to examine the effect of physical activity (PA) on health through changes in multi-omics biomarkers during 6 months of exercise intervention.

NCT ID: NCT05927103 Completed - Healthy Clinical Trials

Differences Between Coffee and Non-coffee Drinkers in the Gut Microbiome and Microbiota-Gut-Brain Axis

Start date: September 21, 2021
Phase:
Study type: Observational

The aim of this study is to investigate the potential of coffee to act as a prebiotic to alter gut microbiota and improve mood, memory and cognitive performance.

NCT ID: NCT05927038 Completed - Healthy Clinical Trials

Coffee Consumption, the Gut Microbiome, and the Microbiota-Gut-Brain Axis

Start date: September 21, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the potential of coffee to act as a prebiotic to alter gut microbiota and improve mood, memory and cognitive performance.

NCT ID: NCT05926648 Completed - Healthy Clinical Trials

Form, Fit, and Function of INVSENSOR00061

Start date: May 12, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the form, fit, and function of INVSENSOR00061 when used on newborn and infant subjects 0-18 months.

NCT ID: NCT05925686 Completed - Healthy Clinical Trials

Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls

Start date: June 1, 2023
Phase: Phase 1
Study type: Interventional

Orally single dose administration of Tramadol 75 mg for ultra-rapid metabolizers and 100 mg for extensive and poor metabolizers will be administered with the objective to evaluate urine and blood concentrations in healthy volunteers.

NCT ID: NCT05925244 Completed - Healthy Clinical Trials

The Anabolic and Catabolic Effect of Loaded and Unloaded Exercise on Articular Cartilage Health

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

The serum concentration of cartilage oligomeric matrix protein (sCOMP) has been considered a mechano-sensitive biomarker of articular cartilage turnover, and N-propeptide of type II collagen (PIIANP) is a proposed biomarker of type II collagen synthesis. Few studies have investigated both the anabolic and turnover response of articular cartilage as a result of acute changes in body weight mass during exercise. Using a repeated measures cross-over design, fifteen healthy adults (age 18-30 years) performed three, 30-minute bouts of treadmill walking exercise under 3 loading conditions: (1) control (no alteration to body mass); (2) loaded (12% increase in body mass using a weighted vest); and (3) unloaded (12% decrease in body mass using lower body positive pressure). Venous blood was collected before, immediately after, and 15 and 30 minutes after exercise to investigate cartilage turnover (sCOMP) and anabolism (PIIANP).

NCT ID: NCT05923671 Completed - Healthy Clinical Trials

Clinical and Histological Analysis of Human Gingival Phenotypes

Start date: March 5, 2020
Phase:
Study type: Observational

The goal of this observational study is to compare the composition of the human gingiva in different gingival phenotypes. The main questions to answer are: - Is there any difference in the cellular composition of the gingiva between thin and thick gingival phenotype? - Is there any difference in the molecular composition of the gingiva between thin and thick gingival phenotype? The participants were divided in two groups (thin and thick phenotype) and a biopsy of healthy gingiva was obtained from each one them. The biopsies were analyzed histologically and the collected data will be analyzed statistically in order to identify possible differences between the gingival phenotypes.

NCT ID: NCT05922709 Completed - Healthy Clinical Trials

A Clinical Trial of CS12192 in Healthy Subjects

Start date: July 20, 2023
Phase: Phase 1
Study type: Interventional

The study is to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of CS12192 after single or multiple oral administration, as well as the food effect on the pharmacokinetics in healthy subjects.